Tuesday 3/22 Insider Buying Report: PCT, RVMD Tuesday, March 22, 11:13 AM ET
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
On Thursday, PureCycle Technologies' Director, Jeffrey Richard Fieler, made a $5M buy of PCT, purchasing 714,284 shares at a cost of $7.00 each. So far Fieler is in the green, up about 33.3% on their buy based on today's trading high of $9.33. PureCycle Technologies is trading up about 2.9% on the day Tuesday. This buy marks the first one filed by Fieler in the past twelve months.
And on Monday, Director Thilo Schroeder purchased $3.43M worth of Revolution Medicines, purchasing 168,051 shares at a cost of $20.40 a piece. Before this latest buy, Schroeder purchased RVMD at 3 other times during the past year, for a total investment of $34.17M at an average of $24.80 per share. Revolution Medicines is trading up about 11.9% on the day Tuesday. So far Schroeder is in the green, up about 14.2% on their purchase based on today's trading high of $23.31.
Paychex Enters Oversold Territory Monday, September 26, 4:17 PM ET, by Market News Video Staff The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, ...
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.